Back

Phenotype Risk Scores: moving beyond cases and controls to classify psychiatric disease in hospital-based biobanks.

Lebovitch, D. S.; Johnson, J. S.; Duenas, H. R.; Huckins, L. M.

2021-01-26 psychiatry and clinical psychology
10.1101/2021.01.25.21249615 medRxiv
Show abstract

Current phenotype classifiers for large biobanks with coupled electronic health records EHR and multi-omic data rely on ICD-10 codes for definition. However, ICD-10 codes are primarily designed for billing purposes, and may be insufficient for research. Nuanced phenotypes composed of a patients experience in the EHR will allow us to create precision psychiatry to predict disease risk, severity, and trajectories in EHR and clinical populations. Here, we create a phenotype risk score (PheRS) for major depressive disorder (MDD) using 2,086 cases and 31,000 individuals from Mount Sinais biobank BioMe . Rather than classifying individuals as cases and controls, PheRS provide a whole-phenome estimate of each individuals likelihood of having a given complex trait. These quantitative scores substantially increase power in EHR analyses and may identify individuals with likely missing diagnoses (for example, those with large numbers of comorbid diagnoses and risk factors, but who lack explicit MDD diagnoses). Our approach applied ten-fold cross validation and elastic net regression to select comorbid ICD-10 codes for inclusion in our PheRS. We identified 158 ICD-10 codes significantly associated with Moderate MDD (F33.1). Phenotype Risk Score were significantly higher among individuals with ICD-10 MDD diagnoses compared to the rest of the population (Kolgorov-Smirnov p<2.2e-16), and were significantly correlated with MDD polygenic risk scores (R2>0.182). Accurate classifiers are imperative for identification of genetic associations with psychiatric disease; therefore, moving forward research should focus on algorithms that can better encompass a patients phenome.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Translational Psychiatry
219 papers in training set
Top 0.2%
17.9%
2
JAMA Psychiatry
13 papers in training set
Top 0.1%
12.0%
3
Biological Psychiatry
119 papers in training set
Top 0.2%
11.9%
4
American Journal of Psychiatry
20 papers in training set
Top 0.1%
8.1%
5
Molecular Psychiatry
242 papers in training set
Top 0.5%
6.1%
50% of probability mass above
6
Nature Medicine
117 papers in training set
Top 0.6%
4.1%
7
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
22 papers in training set
Top 0.1%
3.5%
8
Biological Psychiatry Global Open Science
54 papers in training set
Top 0.2%
3.5%
9
Neuropsychopharmacology
134 papers in training set
Top 1%
2.3%
10
Nature Mental Health
18 papers in training set
Top 0.1%
2.3%
11
Schizophrenia Bulletin
29 papers in training set
Top 0.4%
2.0%
12
Psychological Medicine
74 papers in training set
Top 0.9%
1.8%
13
Nature Neuroscience
216 papers in training set
Top 4%
1.7%
14
Nature Communications
4913 papers in training set
Top 53%
1.6%
15
Journal of Affective Disorders
81 papers in training set
Top 1%
1.6%
16
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 1.0%
1.6%
17
Nature Genetics
240 papers in training set
Top 6%
1.2%
18
Frontiers in Psychiatry
83 papers in training set
Top 2%
1.2%
19
Genome Medicine
154 papers in training set
Top 6%
1.2%
20
European Neuropsychopharmacology
15 papers in training set
Top 0.5%
0.9%
21
Science Advances
1098 papers in training set
Top 27%
0.9%
22
The British Journal of Psychiatry
21 papers in training set
Top 0.9%
0.8%
23
Communications Medicine
85 papers in training set
Top 1%
0.8%
24
NeuroImage: Clinical
132 papers in training set
Top 4%
0.7%
25
Brain, Behavior, and Immunity
105 papers in training set
Top 3%
0.7%
26
PLOS ONE
4510 papers in training set
Top 72%
0.6%
27
Acta Psychiatrica Scandinavica
10 papers in training set
Top 0.6%
0.6%